Activity of Tedizolid against Gram-Positive Clinical Isolates Causing Nosocomial- and Community-Acquired Infections in United States Hospitals (2014–2016)

BACKGROUND: Tedizolid (TZD) was approved for the treatment of acute bacterial skin and skin structure infections and is also under investigation for the treatment of hospital-acquired (HA) bacterial pneumonia. The activity of TZD and comparators were evaluated against gram-positive (GP) pathogens ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Shortridge, Dee, Arends, S J Ryan, Sader, Helio S, Castanheira, Mariana, Flamm, Robert K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631071/
http://dx.doi.org/10.1093/ofid/ofx163.911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631071/
http://dx.doi.org/10.1093/ofid/ofx163.911

Ejemplares similares